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Introduction
A very common type of 
dilated cardiomyopathy is 
ischemic cardiomyopathy.  
Ischemic cardiomyopathy 
is very important to review 
due to its ability to affect a 
patient’s health in a major 
way. Coronary artery 
disease is one of the top 
killers in America; Ischemic 
cardiomyopathy involves it 
and a weakened heart 
muscle. This weakened 
heart muscle can cause an 
array of problems for the 
patient.  Education of 
diseases is important for 
nurses so we can better 
treat and educate our 
patients. With working in 
the cardiac catheterization 
lab, seeing patients with 
ischemic disease is very 
common. Making patients 
aware of the signs and 
symptoms of coronary 
disease is important so it 
can be revascularized and 




• The diagnosis of ischemic 






test, imaging studies, and 
coronary catheterization.
• Cardiovascular magnetic 
resonance imaging allows 
the assessment of 
myocardial function, 
perfusion, contractile 
reserve and extent of 
fibrosis in a single 
comprehensive exam. This 
is a great non-invasive tool 
to use for diagnosis and 
treatment options. It 
detects myocardial 
ischemia, viability of the 
muscle, and the extent of 
myocardial scarring, this 
information helps 
physician know to perform 
revascularization, implant 
a defibrillator, or which 




implication of nursing care for 
ischemic cardiomyopathy is 
patient education. The nurse 
should educate the patient of the 
following:
• Diet- restriction of sodium to 
2,000-3,000 mg per day
• Sudden weight gain- more 
than 3 pounds in 2 days
• Exercise- Non-competitive 
aerobic exercises
• Feelings of lightheaded or 
palpitations- call physician
• Take prescribed medications
Underlying Pathophysiology
According to Aksut MD, B. & Bott-Silverman MD, C., (2015)
• Ischemic cardiomyopathy is the most commonly identified specific cause of 
dilated cardiomyopathy
• Myocardial infarction causes localized myocyte necrosis, with resultant scar 
formation and loss of contractile function in the ventricular segment perfused 
by the culprit artery. In addition, the myocardium distal to the area of 
infarction develops increased wall stress, adverse remodeling, and chamber 
dilation, so that a cardiomyopathic process occurs in adjacent nonischemic
areas.
• Ischemic cardiomyopathy is generally ascribed to epicardial coronary 
atherosclerosis, but it can also occur in any vasculitic process (eg, Takayasu’s
arteritis), congenital abnormalities, embolic conditions (eg, atrial fibrillation, 
endocarditis, thrombophilic states), cardiac allograft vasculopathy, and 
microvascular ischemia.
• Ischemic cardiomyopathy can occur as the direct result of myocardial 
infarction or can result from repetitive ischemic results in those with poorly 
controlled angina
• .Decreased blood flow to the cardiac muscle makes it weak or even die, which 
decreases its functionality as a pump.
Significance of Pathophysiology
• Due to the lack of blood flow to the cardiac muscle from coronary artery 
disease the muscle becomes weak and dilated. The pump function is 
decreased which then causes the symptoms listed. 
• Without an adequate pump function, the fluid is not pushed out which then 
causes fluid retention in the heart, lungs, and extremities. This is why the 
shortness of breath and edema. 
• The ischemia causes the chest pain or angina; revascularization can be 
performed to help reduce the angina. 
• The weak heart muscle can then cause arrhythmias which can be fatal.
• Implantable Cardioverter Defibrillators are implanted to help prevent death 
due to fatal arrhythmias from the weak heart muscle. 
Signs & Symptoms
• Shortness of breath
• Swelling of the legs and feet
• Fatigue
• Angina (Chest pain)
• Weight gain, cough and 
congestion related to fluid 
retention




1. Medications such as beta-
blockers, ACE Inhibitors, 
digoxin, diuretics, aldosterone 
inhibitors, and nitrates.
2. Lifestyle changes of diet and 
exercise
3. Implantable Devices- Cardiac 
Resynchronization Therapy 
or Implantable Cardioverter 
Defibrillators
4. Revascularization-
Angioplasty, stents, or 
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